Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert M Rifkin, MD, FACP
US Oncology Research/McKesson Specialty Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Oncology Associates, Pc - Hope
Tucson, Arizona, United States
- Rocky Mountain Cancer Centers
Denver, Colorado, United States
- Maryland Oncology Hematology, P.A.
Columbia, Maryland, United States
- New York Oncology Hematology, P.C.
Albany, New York, United States
- Willamette Valley Cancer Institute and Research Center
Eugene, Oregon, United States
- Texas Oncology, P.A.
Austin, Texas, United States
- Texas Oncology, P.A.
Fort Worth, Texas, United States
- Texas Oncology, P.A.
San Antonio, Texas, United States
- Texas Oncology, P.A.
Tyler, Texas, United States
- Virginia Cancer Specialists, Pc
Gainesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Sept 2021
- Primary completion
- 31 May 2026
- Completion
- 31 May 2026
- Last update posted
- 16 Jan 2025
- Registered enrollment
- 73
- Registry id
- NCT04782687
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.